Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Despite improved transparency, conflicts of interest remain issue in medicine
• Cardiology-oncology: A new focus for CV medicine W. Gregory Hundley, MD
• Ablation system provides real-time visualization during procedure
• Broad scope, visual aids on DVD enhance cardiac CT text David E. Winchester, MD
• Dabigatran found cost-effective in high-risk patients with AF
• FDA approves Xience Nano for treatment of CAD
• FDA issues changes to simvastatin safety labeling
• Leukocyte count predictive of outcome in patients with STEMI treated with PCI
• Lung-specific biomarker predictive of CV morbidity, mortality
• MESA substudy: Patient characteristics influence size, ejection fraction of right ventricle
• MI rate fell nearly 75% in London cohort during 20-year period
• Mortality, adverse events found higher in patients with elevated biomarkers after nonemergent PCI
• New modality offers noninvasive look into arrhythmias
• Omega-3 may benefit patients undergoing PCI
• SHIFT data reveal key improvements with ivabradine
• Sleep-disordered breathing increased arrhythmias in patients with ICDs
• ASA-STAT: Aspirin, simvastatin failed to benefit patients with PAH
• Echocardiographic measurements promising for predicting improvement after elective PCI
• Recurrent stroke, vascular event rate on decline during past 50 years
• SCCT document helps align CT terminology
• Younger physicians may be more likely to prescribe CVD drugs
• Coffee intake led to short-term rise in BP for patients with hypertension
• High prevalence of masked hypertension confirmed among blacks
• New combination therapy offers promising approach for hypertension management
• Medication shortage du jour: Root-cause analysis J. Erin Allender, PharmD, BCPS